GL1X · GenesisL1 explorer

Research workbench

Crystal structure of spectinomycin phosphotransferase, APH(9)-ia, protein kinase inhibitor cki-7 complex

Analyse Crystal structure of spectinomycin phosphotransferase, APH(9)-ia, protein… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3Q2M
Type
protein
Length
329 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spectinomycin phosphotransferase
UniProt
E1XXQ2
Ligands
CKI, NI
Pockets
3 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASpectinomycin phosphotransferaseprotein32944% helix, 15% strandE1XXQ2

Ligands and binding sites

  • CKI · N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide · ligand · chains A
  • NI · Nickel (II) ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17710.740.7973CKI
2640.370.7815empty
3640.300.7415empty

Compared structures

  • 3Q2M · Crystal Structure of Spectinomycin Phosphotransferase, APH(9)-Ia, Protein Kinase… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.